Human islet transplantation

Update

Andres Boker, Lisa Rothenberg, Claudia Hernandez, Norma S Kenyon, Camillo Ricordi, Rodolfo Alejandro

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

New hope for the treatment of type 1 diabetes has recently emerged from the encouraging results of islet cell transplantation in humans during the last few years. Although still facing considerable problems, the challenge to achieving insulin independence has been overcome in some patients who received an islet graft. However; the success of clinical trials is still limited by the inability to transplant enough viable human islets to compensate for the insulin-deficient state, the number of islets that engraft following transplantation, the rejection process, and the recurrence of autoimmunity. The important advances in immunosuppressive regimens, organ procurement techniques, isolation techniques, and availability of defined collagenase blends have contributed to the continuing promise of making islet cell transplantation the treatment of choice for type 1 diabetes mellitus.

Original languageEnglish
Pages (from-to)481-486
Number of pages6
JournalWorld Journal of Surgery
Volume25
Issue number4
DOIs
StatePublished - Apr 1 2001

Fingerprint

Islets of Langerhans Transplantation
Cell Transplantation
Type 1 Diabetes Mellitus
Islets of Langerhans
Insulin
Transplants
Tissue and Organ Procurement
Graft Rejection
Collagenases
Immunosuppressive Agents
Autoimmunity
Clinical Trials
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Human islet transplantation : Update. / Boker, Andres; Rothenberg, Lisa; Hernandez, Claudia; Kenyon, Norma S; Ricordi, Camillo; Alejandro, Rodolfo.

In: World Journal of Surgery, Vol. 25, No. 4, 01.04.2001, p. 481-486.

Research output: Contribution to journalArticle

Boker, Andres ; Rothenberg, Lisa ; Hernandez, Claudia ; Kenyon, Norma S ; Ricordi, Camillo ; Alejandro, Rodolfo. / Human islet transplantation : Update. In: World Journal of Surgery. 2001 ; Vol. 25, No. 4. pp. 481-486.
@article{f31558ca1d394cbfa82677ab9669b159,
title = "Human islet transplantation: Update",
abstract = "New hope for the treatment of type 1 diabetes has recently emerged from the encouraging results of islet cell transplantation in humans during the last few years. Although still facing considerable problems, the challenge to achieving insulin independence has been overcome in some patients who received an islet graft. However; the success of clinical trials is still limited by the inability to transplant enough viable human islets to compensate for the insulin-deficient state, the number of islets that engraft following transplantation, the rejection process, and the recurrence of autoimmunity. The important advances in immunosuppressive regimens, organ procurement techniques, isolation techniques, and availability of defined collagenase blends have contributed to the continuing promise of making islet cell transplantation the treatment of choice for type 1 diabetes mellitus.",
author = "Andres Boker and Lisa Rothenberg and Claudia Hernandez and Kenyon, {Norma S} and Camillo Ricordi and Rodolfo Alejandro",
year = "2001",
month = "4",
day = "1",
doi = "10.1007/s002680020341",
language = "English",
volume = "25",
pages = "481--486",
journal = "World Journal of Surgery",
issn = "0364-2313",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Human islet transplantation

T2 - Update

AU - Boker, Andres

AU - Rothenberg, Lisa

AU - Hernandez, Claudia

AU - Kenyon, Norma S

AU - Ricordi, Camillo

AU - Alejandro, Rodolfo

PY - 2001/4/1

Y1 - 2001/4/1

N2 - New hope for the treatment of type 1 diabetes has recently emerged from the encouraging results of islet cell transplantation in humans during the last few years. Although still facing considerable problems, the challenge to achieving insulin independence has been overcome in some patients who received an islet graft. However; the success of clinical trials is still limited by the inability to transplant enough viable human islets to compensate for the insulin-deficient state, the number of islets that engraft following transplantation, the rejection process, and the recurrence of autoimmunity. The important advances in immunosuppressive regimens, organ procurement techniques, isolation techniques, and availability of defined collagenase blends have contributed to the continuing promise of making islet cell transplantation the treatment of choice for type 1 diabetes mellitus.

AB - New hope for the treatment of type 1 diabetes has recently emerged from the encouraging results of islet cell transplantation in humans during the last few years. Although still facing considerable problems, the challenge to achieving insulin independence has been overcome in some patients who received an islet graft. However; the success of clinical trials is still limited by the inability to transplant enough viable human islets to compensate for the insulin-deficient state, the number of islets that engraft following transplantation, the rejection process, and the recurrence of autoimmunity. The important advances in immunosuppressive regimens, organ procurement techniques, isolation techniques, and availability of defined collagenase blends have contributed to the continuing promise of making islet cell transplantation the treatment of choice for type 1 diabetes mellitus.

UR - http://www.scopus.com/inward/record.url?scp=0035016543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035016543&partnerID=8YFLogxK

U2 - 10.1007/s002680020341

DO - 10.1007/s002680020341

M3 - Article

VL - 25

SP - 481

EP - 486

JO - World Journal of Surgery

JF - World Journal of Surgery

SN - 0364-2313

IS - 4

ER -